Financials Medinotec Inc.

Equities

MDNC

US58500G1076

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for Medinotec Inc. -.--% -.--%

Valuation

Fiscal Period: February 2024
Capitalization 1 58.67
Enterprise Value (EV) 1 57.69
P/E ratio -145 x
Yield -
Capitalization / Revenue 11,686,092 x
EV / Revenue 11,491,896 x
EV / EBITDA 83,759,523 x
EV / FCF -6,805,923,204 x
FCF Yield -0%
Price to Book 27.1 x
Nbr of stocks (in thousands) 11,734
Reference price 2 5.000
Announcement Date 7/5/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: February 2022 2023 2024
Net sales - 0.9996 5.02
EBITDA - -0.1774 0.6888
EBIT 1 -0.00061 -0.231 0.6006
Operating Margin - -23.11% 11.96%
Earnings before Tax (EBT) 1 -0.00061 -0.3915 -0.2538
Net income 1 -0.00061 -0.3527 -0.4047
Net margin - -35.29% -8.06%
EPS - -0.0300 -0.0345
Free Cash Flow - -0.3269 -0.008477
FCF margin - -32.71% -0.17%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 6/2/22 5/30/23 7/5/24
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: February 2022 2023 2024
Net Debt 1 - - -
Net Cash position 1 0.01 0.96 0.97
Leverage (Debt/EBITDA) - - -
Free Cash Flow - -0.33 -0.01
ROE (net income / shareholders' equity) - -33.8% -17.1%
ROA (Net income/ Total Assets) - -4.97% 8.08%
Assets 1 - 7.102 -5.01
Book Value Per Share 2 0 0.2200 0.1800
Cash Flow per Share 2 0 0.2400 0.2400
Capex - - 0
Capex / Sales - - 0.04%
Announcement Date 6/2/22 5/30/23 7/5/24
1USD in Million2USD
Estimates
  1. Stock Market
  2. Equities
  3. MDNC Stock
  4. Financials Medinotec Inc.